omeprazole
The following drugs will decrease omeprazole effect
# | enzyme | inducers |
0 | 3A457 | barbiturates |
1 | 3A457 | brigatinib |
2 | 2C19 | carbamazepine |
3 | 3A457 | carbamazepine |
4 | 3A457 | clobazam |
5 | 3A457 | dabrafenib |
6 | 2C19 | efavirenz |
7 | 3A457 | efavirenz |
8 | 2C19 | enzalutamide |
9 | 3A457 | elagolix |
10 | 3A457 | enzalutamide |
11 | 2C19 | letermovir |
12 | 3A457 | eslicarbazepine |
13 | 3A457 | glucocorticoids |
14 | 3A457 | letermovir |
15 | 3A457 | lorlatinib |
16 | 3A457 | modafinil |
17 | 3A457 | nevirapine |
18 | 3A457 | oxcarbazepine |
19 | 2C19 | norethindrone |
20 | 3A457 | perampanel |
21 | 2C19 | prednisone |
22 | 2C19 | rifampicin |
23 | 3A457 | phenobarbital |
24 | 2C19 | ritonavir |
25 | 3A457 | phenytoin |
26 | 3A457 | pioglitazone |
27 | 3A457 | rifabutin |
28 | 3A457 | rifampin |
29 | 3A457 | St. John's Wort |
30 | 3A457 | telotristat |
31 | 3A457 | troglitazone |
32 | 3A457 | vemurafenib |
the follwing drugs will
Increase omeprazole effect
# | enzyme | Inhibitors | level |
0 | 3A457 | amiodarone | under review |
1 | 3A457 | aprepitant | Moderate inhibitor |
2 | 2C19 | armodafinil | Weak inhibitor |
3 | 3A457 | atomoxetine | |
4 | 3A457 | boceprevir | under review |
5 | 3A457 | ceritinib | Strong inhibitor |
6 | 2C19 | chloramphenicol | In-Vitro Only |
7 | 3A457 | chloramphenicol | In-Vitro Only |
8 | 2C19 | cimetidine | Weak inhibitor |
9 | 3A457 | cimetidine | |
10 | 3A457 | ciprofloxacin | under review |
11 | 2C19 | citalopram | Weak inhibitor |
12 | 3A457 | clarithromycin | Strong inhibitor |
13 | 3A457 | crizotinib | Moderate inhibitor |
14 | 3A457 | delaviridine | under review |
15 | 3A457 | diethyl-dithiocarbamate | |
16 | 3A457 | diltiazem | Moderate inhibitor |
17 | 3A457 | entrectinib | |
18 | 3A457 | erythromycin | Moderate inhibitor |
19 | 2C19 | esomeprazole | Weak inhibitor |
20 | 3A457 | esomeprazole | |
21 | 2C19 | felbamate | Weak inhibitor |
22 | 2C19 | fluconazole | Moderate inhibitor |
23 | 3A457 | fluconazole | Moderate inhibitor |
24 | 2C19 | fluoxetine | Moderate inhibitor |
25 | 2C19 | fluvoxamine | Strong inhibitor |
26 | 3A457 | fluvoxamine | under review |
27 | 3A457 | gestodene | under review |
28 | 3A457 | grapefruit juice | Moderate inhibitor |
29 | 3A457 | idelalisib | Strong inhibitor |
30 | 3A457 | imatinib | under review |
31 | 3A457 | indinavir | Strong inhibitor |
32 | 2C19 | isoniazid | Weak inhibitor |
33 | 3A457 | itraconazole | Strong inhibitor |
34 | 3A457 | ivacaftor | |
35 | 2C19 | ketoconazole | Moderate inhibitor |
36 | 3A457 | ketoconazole | Strong inhibitor |
37 | 3A457 | lesinurad | |
38 | 3A457 | letermovir | |
39 | 2C19 | luliconazole | Weak inhibitor |
40 | 3A457 | mibefradil | Strong inhibitor |
41 | 3A457 | mifepristone | under review |
42 | 2C19 | modafinil | Weak inhibitor |
43 | 3A457 | nefazodone | Strong inhibitor |
44 | 3A457 | nelfinavir | Strong inhibitor |
45 | 3A457 | netupitant/palonosetron | Moderate inhibitor |
46 | 3A457 | norfloxacin | under review |
47 | 3A457 | norfluoxetine | under review |
48 | 3A457 | omeprazole | Weak inhibitor |
49 | 2C19 | oral contraceptives | Weak inhibitor |
50 | 2C19 | oritavancin | In-Vitro Only |
51 | 2C19 | pantoprazole | Weak inhibitor |
52 | 3A457 | pantoprazole | |
53 | 3A457 | perampanel | |
54 | 2C19 | quercetin | In-Vitro Only |
55 | 3A457 | quercetin | |
56 | 3A457 | regorafenib | under review |
57 | 3A457 | ribociclib | Strong inhibitor |
58 | 3A457 | ritonavir | Strong inhibitor |
59 | 3A457 | rucaparib | |
60 | 3A457 | saquinavir | Strong inhibitor |
61 | 3A457 | simeprevir | |
62 | 3A457 | starfruit | under review |
63 | 3A457 | telaprevir | under review |
64 | 3A457 | telithromycin | Strong inhibitor |
65 | 3A457 | ticagrelor | |
66 | 2C19 | ticlopidine | Strong inhibitor |
67 | 2C19 | topiramate | under review |
68 | 3A457 | tucatinib | Strong inhibitor |
69 | 3A457 | verapamil | Moderate inhibitor |
70 | 2C19 | voriconazole | Moderate inhibitor |
71 | 3A457 | voriconazole | Strong inhibitor |
The follwing drugs will Increase effect by omeprazole effect
# | enzyme | drug | level |
1 | 3A457 | abemaciclib | Weak inhibitor |
2 | 3A457 | abiraterone | Weak inhibitor |
3 | 3A457 | acalabrutinib | Weak inhibitor |
4 | 3A457 | alectinib | Weak inhibitor |
5 | 3A457 | alfentanil | Weak inhibitor |
6 | 3A457 | alprazolam | Weak inhibitor |
7 | 2C19 | amitriptyline | Weak inhibitor |
8 | 3A457 | amitriptyline | Weak inhibitor |
9 | 3A457 | amlodipine | Weak inhibitor |
10 | 3A457 | apixaban | Weak inhibitor |
11 | 3A457 | aprepitant | Weak inhibitor |
12 | 3A457 | aripiprazole | Weak inhibitor |
13 | 3A457 | astemizole | Weak inhibitor |
14 | 2C19 | atomoxetine | Weak inhibitor |
15 | 3A457 | atorvastatin | Weak inhibitor |
16 | 3A457 | avanafil | Weak inhibitor |
17 | 3A457 | axitinib | Weak inhibitor |
18 | 3A457 | boceprevir | Weak inhibitor |
19 | 3A457 | bosutinib | Weak inhibitor |
20 | 3A457 | brexpiprazole | Weak inhibitor |
21 | 3A457 | brigatinib | Weak inhibitor |
22 | 2C19 | brivaracetam | Weak inhibitor |
23 | 3A457 | buspirone | Weak inhibitor |
24 | 3A457 | cafergot | Weak inhibitor |
25 | 3A457 | caffeine | Weak inhibitor |
26 | 3A457 | carbamazepine | Weak inhibitor |
27 | 3A457 | cariprazine | Weak inhibitor |
28 | 2C19 | carisoprodol | Weak inhibitor |
29 | 2C19 | celecoxib | Weak inhibitor |
30 | 3A457 | ceritinib | Weak inhibitor |
31 | 3A457 | cerivastatin | Weak inhibitor |
32 | 2C19 | chloramphenicol | Weak inhibitor |
33 | 3A457 | chlorpheniramine | Weak inhibitor |
34 | 3A457 | cilostazol | Weak inhibitor |
35 | 3A457 | cisapride | Weak inhibitor |
36 | 2C19 | citalopram | Weak inhibitor |
37 | 3A457 | citalopram | Weak inhibitor |
38 | 3A457 | clarithromycin | Weak inhibitor |
39 | 2C19 | clobazam | Weak inhibitor |
40 | 3A457 | clobazam | Weak inhibitor |
41 | 2C19 | clomipramine | Weak inhibitor |
42 | 2C19 | clopidogrel | Weak inhibitor |
43 | 3A457 | clopidogrel | Weak inhibitor |
44 | 3A457 | cobimetinib | Weak inhibitor |
45 | 3A457 | cocaine | Weak inhibitor |
46 | 3A457 | codeine | Weak inhibitor |
47 | 3A457 | colchicine | Weak inhibitor |
48 | 3A457 | copanlisib | Weak inhibitor |
49 | 3A457 | crizotinib | Weak inhibitor |
50 | 2C19 | cyclophosphamide | Weak inhibitor |
51 | 3A457 | cyclosporine | Weak inhibitor |
52 | 3A457 | dabrafenib | Weak inhibitor |
53 | 3A457 | daclatasvir | Weak inhibitor |
54 | 3A457 | dapsone | Weak inhibitor |
55 | 3A457 | deflazacort | Weak inhibitor |
56 | 3A457 | dexamethasone | Weak inhibitor |
57 | 3A457 | dextromethorphan | Weak inhibitor |
58 | 2C19 | diazepam | Weak inhibitor |
59 | 3A457 | diazepam | Weak inhibitor |
60 | 3A457 | diltiazem | Weak inhibitor |
61 | 3A457 | docetaxel | Weak inhibitor |
62 | 3A457 | dolutegravir | Weak inhibitor |
63 | 3A457 | domperidone | Weak inhibitor |
64 | 2C19 | doxepin | Weak inhibitor |
65 | 3A457 | doxepin | Weak inhibitor |
66 | 3A457 | elagolix | Weak inhibitor |
67 | 3A457 | elbasvir/grazoprevir | Weak inhibitor |
68 | 3A457 | eliglustat | Weak inhibitor |
69 | 3A457 | enzalutamide | Weak inhibitor |
70 | 3A457 | eplerenone | Weak inhibitor |
71 | 3A457 | erythromycin2 | Weak inhibitor |
72 | 2C19 | escitalopram | Weak inhibitor |
73 | 3A457 | escitalopram | Weak inhibitor |
74 | 2C19 | esomeprazole | Weak inhibitor |
75 | 3A457 | esomeprazole | Weak inhibitor |
76 | 3A457 | estradiol | Weak inhibitor |
77 | 3A457 | felodipine | Weak inhibitor |
78 | 3A457 | fentanyl | Weak inhibitor |
79 | 3A457 | finasteride | Weak inhibitor |
80 | 2C19 | flibanserin | Weak inhibitor |
81 | 3A457 | flibanserin | Weak inhibitor |
82 | 3A457 | gleevec | Weak inhibitor |
83 | 3A457 | haloperidol | Weak inhibitor |
84 | 2C19 | hexobarbital | Weak inhibitor |
85 | 3A457 | hydrocortisone | Weak inhibitor |
86 | 3A457 | ibrutinib | Weak inhibitor |
87 | 3A457 | idelalisib | Weak inhibitor |
88 | 2C19 | imipramine | Weak inhibitor |
89 | 3A457 | indacaterol | Weak inhibitor |
90 | 3A457 | indinavir | Weak inhibitor |
91 | 2C19 | indomethacin | Weak inhibitor |
92 | 3A457 | irinotecan | Weak inhibitor |
93 | 3A457 | isavuconazonium | Weak inhibitor |
94 | 3A457 | ivabradine | Weak inhibitor |
95 | 3A457 | ivacaftor | Weak inhibitor |
96 | 3A457 | LAAM | Weak inhibitor |
97 | 2C19 | labetalol | Weak inhibitor |
98 | 2C19 | lansoprazole | Weak inhibitor |
99 | 3A457 | lansoprazole | Weak inhibitor |
100 | 3A457 | lenvatinib | Weak inhibitor |
101 | 3A457 | lercanidipine | Weak inhibitor |
102 | 3A457 | lidocaine | Weak inhibitor |
103 | 3A457 | linagliptin | Weak inhibitor |
104 | 3A457 | lovastatin | Weak inhibitor |
105 | 3A457 | macitentan | Weak inhibitor |
106 | 2C19 | mavacamten | Weak inhibitor |
107 | 3A457 | mavacamten | Weak inhibitor |
108 | 3A457 | methadone | Weak inhibitor |
109 | 3A457 | midazolam | Weak inhibitor |
110 | 2C19 | moclobemide | Weak inhibitor |
111 | 3A457 | naldemedine | Weak inhibitor |
112 | 3A457 | naloxegol | Weak inhibitor |
113 | 3A457 | nateglinide | Weak inhibitor |
114 | 2C19 | nelfinavir | Weak inhibitor |
115 | 3A457 | nelfinavir | Weak inhibitor |
116 | 3A457 | neratinib | Weak inhibitor |
117 | 3A457 | netupitant/palonosetron | Weak inhibitor |
118 | 3A457 | nevirapine | Weak inhibitor |
119 | 3A457 | nifedipine | Weak inhibitor |
120 | 2C19 | nilutamide | Weak inhibitor |
121 | 3A457 | nirmatrelvir | Weak inhibitor |
122 | 3A457 | nisoldipine | Weak inhibitor |
123 | 3A457 | nitrendipine | Weak inhibitor |
124 | 3A457 | olaparib | Weak inhibitor |
125 | 3A457 | omeprazole | Weak inhibitor |
126 | 3A457 | ondansetron | Weak inhibitor |
127 | 3A457 | osimertinib | Weak inhibitor |
128 | 2C19 | ospemifene | Weak inhibitor |
129 | 3A457 | ospemifene | Weak inhibitor |
130 | 3A457 | palbociclib | Weak inhibitor |
131 | 3A457 | panobinostat | Weak inhibitor |
132 | 2C19 | pantoprazole | Weak inhibitor |
133 | 3A457 | pantoprazole | Weak inhibitor |
134 | 3A457 | perampanel | Weak inhibitor |
135 | 2C19 | phenobarbitone | Weak inhibitor |
136 | 2C19 | phenytoin | Weak inhibitor |
137 | 3A457 | pimavanserin | Weak inhibitor |
138 | 3A457 | pimozide | Weak inhibitor |
139 | 2C19 | pomalidomide | Weak inhibitor |
140 | 3A457 | pomalidomide | Weak inhibitor |
141 | 3A457 | ponatinib | Weak inhibitor |
142 | 2C19 | primidone | Weak inhibitor |
143 | 2C19 | progesterone | Weak inhibitor |
144 | 3A457 | progesterone | Weak inhibitor |
145 | 2C19 | proguanil | Weak inhibitor |
146 | 2C19 | propranolol | Weak inhibitor |
147 | 3A457 | propranolol | Weak inhibitor |
148 | 3A457 | quetiapine | Weak inhibitor |
149 | 3A457 | quinidine | Weak inhibitor |
150 | 3A457 | quinine | Weak inhibitor |
151 | 2C19 | r-mephobarbital | Weak inhibitor |
152 | 2C19 | r-warfarin | Weak inhibitor |
153 | 3A457 | regorafenib | Weak inhibitor |
154 | 3A457 | ribociclib | Weak inhibitor |
155 | 3A457 | rilpivirine | Weak inhibitor |
156 | 3A457 | risperidone | Weak inhibitor |
157 | 3A457 | ritonavir | Weak inhibitor |
158 | 3A457 | rivaroxaban | Weak inhibitor |
159 | 3A457 | roflumilast | Weak inhibitor |
160 | 3A457 | rolapitant | Weak inhibitor |
161 | 3A457 | romidepsin | Weak inhibitor |
162 | 3A457 | rucaparib | Weak inhibitor |
163 | 3A457 | ruxolitinib | Weak inhibitor |
164 | 2C19 | s-mephenytoin | Weak inhibitor |
165 | 3A457 | salmeterol | Weak inhibitor |
166 | 3A457 | saquinavir | Weak inhibitor |
167 | 3A457 | selexipag | Weak inhibitor |
168 | 3A457 | sildenafil | Weak inhibitor |
169 | 3A457 | simeprevir | Weak inhibitor |
170 | 3A457 | simvastatin | Weak inhibitor |
171 | 3A457 | sirolimus | Weak inhibitor |
172 | 3A457 | sonidegib | Weak inhibitor |
173 | 3A457 | sorafenib | Weak inhibitor |
174 | 3A457 | sunitinib | Weak inhibitor |
175 | 2C19 | suvorexant | Weak inhibitor |
176 | 3A457 | suvorexant | Weak inhibitor |
177 | 3A457 | tacrolimus(fk506) | Weak inhibitor |
178 | 3A457 | tamoxifen | Weak inhibitor |
179 | 3A457 | tasimelteon | Weak inhibitor |
180 | 3A457 | taxol | Weak inhibitor |
181 | 3A457 | telaprevir | Weak inhibitor |
182 | 3A457 | telithromycin | Weak inhibitor |
183 | 2C19 | teniposide | Weak inhibitor |
184 | 3A457 | terfenadine | Weak inhibitor |
185 | 3A457 | testosterone | Weak inhibitor |
186 | 3A457 | ticagrelor | Weak inhibitor |
187 | 2C19 | tofacitinib | Weak inhibitor |
188 | 3A457 | tofacitinib | Weak inhibitor |
189 | 3A457 | tolvaptan | Weak inhibitor |
190 | 3A457 | torisel | Weak inhibitor |
191 | 3A457 | tramadol | Weak inhibitor |
192 | 3A457 | trazodone | Weak inhibitor |
193 | 3A457 | valbenazine | Weak inhibitor |
194 | 3A457 | vandetanib | Weak inhibitor |
195 | 3A457 | velpatasvir | Weak inhibitor |
196 | 3A457 | vemurafenib | Weak inhibitor |
197 | 3A457 | venetoclax | Weak inhibitor |
198 | 2C19 | venlafaxine | Weak inhibitor |
199 | 3A457 | venlafaxine | Weak inhibitor |
200 | 3A457 | verapamil | Weak inhibitor |
201 | 2C19 | vilazodone | Weak inhibitor |
202 | 3A457 | vilazodone | Weak inhibitor |
203 | 3A457 | vincristine | Weak inhibitor |
204 | 3A457 | vorapaxar | Weak inhibitor |
205 | 2C19 | voriconazole | Weak inhibitor |
206 | 3A457 | voriconazole | Weak inhibitor |
207 | 3A457 | zaleplon | Weak inhibitor |
208 | 3A457 | ziprasidone | Weak inhibitor |
209 | 3A457 | zolpidem | Weak inhibitor |
The following drugs will decreased effect by omeprazole effect
# | enzyme | drug |
1 | 1A2 | acetaminophen |
2 | 1A2 | amitriptyline |
3 | 1A2 | apremilast |
4 | 1A2 | caffeine |
5 | 1A2 | clomipramine |
6 | 1A2 | clozapine |
7 | 1A2 | cyclobenzaprine |
8 | 1A2 | doxepin |
9 | 1A2 | duloxetine |
10 | 1A2 | estradiol |
11 | 1A2 | fluvoxamine |
12 | 1A2 | haloperidol |
13 | 1A2 | imipramine |
14 | 1A2 | mexiletine |
15 | 1A2 | nabumetone |
16 | 1A2 | naproxen |
17 | 1A2 | olanzapine |
18 | 1A2 | ondansetron |
19 | 1A2 | phenacetin |
20 | 1A2 | pirfenidone |
21 | 1A2 | pomalidomide |
22 | 1A2 | propranolol |
23 | 1A2 | riluzole |
24 | 1A2 | roflumilast |
25 | 1A2 | ropivacaine |
26 | 1A2 | rucaparib |
27 | 1A2 | tacrine |
28 | 1A2 | tasimelteon |
29 | 1A2 | theophylline |
30 | 1A2 | tizanidine |
31 | 1A2 | triamterene |
32 | 1A2 | verapamil |
33 | 1A2 | warfarin |
34 | 1A2 | zileuton |
35 | 1A2 | zolmitriptan |
will
decrease omeprazole effect
omeprazole will not affect
Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.